DD254193A5 - Verfahren zur herstellung von carbonsaeurederivaten - Google Patents

Verfahren zur herstellung von carbonsaeurederivaten Download PDF

Info

Publication number
DD254193A5
DD254193A5 DD86292398A DD29239886A DD254193A5 DD 254193 A5 DD254193 A5 DD 254193A5 DD 86292398 A DD86292398 A DD 86292398A DD 29239886 A DD29239886 A DD 29239886A DD 254193 A5 DD254193 A5 DD 254193A5
Authority
DD
German Democratic Republic
Prior art keywords
chlorophenyl
acid
group
sulfonyl
methylphenyl
Prior art date
Application number
DD86292398A
Other languages
German (de)
English (en)
Inventor
Hans P Wolff
Ernst-Christian Witte
Hans-Frieder Kuehnle
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD254193A5 publication Critical patent/DD254193A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD86292398A 1985-07-16 1986-07-11 Verfahren zur herstellung von carbonsaeurederivaten DD254193A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853525284 DE3525284A1 (de) 1985-07-16 1985-07-16 Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
DD254193A5 true DD254193A5 (de) 1988-02-17

Family

ID=6275845

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86292398A DD254193A5 (de) 1985-07-16 1986-07-11 Verfahren zur herstellung von carbonsaeurederivaten

Country Status (21)

Country Link
US (1) US4933367A (fr)
EP (1) EP0226636B1 (fr)
JP (1) JPS63500310A (fr)
KR (1) KR870700599A (fr)
AT (1) ATE40681T1 (fr)
AU (2) AU595814B2 (fr)
CA (1) CA1316922C (fr)
DD (1) DD254193A5 (fr)
DE (2) DE3525284A1 (fr)
DK (1) DK100487A (fr)
ES (1) ES2001163A6 (fr)
FI (1) FI871143A0 (fr)
GR (1) GR861803B (fr)
IL (1) IL79379A0 (fr)
NO (1) NO166939C (fr)
NZ (1) NZ216830A (fr)
PH (1) PH25313A (fr)
PT (1) PT82987B (fr)
SU (1) SU1708156A3 (fr)
WO (1) WO1987000521A2 (fr)
ZA (1) ZA865192B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007265A1 (fr) * 1986-05-29 1987-12-03 E.I. Du Pont De Nemours And Company Acylation et sulfonation d'acetales de silylcetene
DE3700729A1 (de) * 1987-01-13 1988-07-21 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3935512A1 (de) * 1989-10-25 1991-05-02 Boehringer Mannheim Gmbh Neues herstellungsverfahren fuer verbindungen mit wertvollen pharmakologischen eigenschaften sowie neue zwischenprodukte zur herstellung dieser verbindungen
DE4112103C2 (de) * 1991-02-18 1994-07-14 Matthias Mueller Verwendung von Essigsäure zur Regulierung der Blutzuckerwerte
JP2785162B2 (ja) * 1991-04-05 1998-08-13 富士写真フイルム株式会社 写真用ポリエステル支持体およびハロゲン化銀写真感光材料
IL115995A0 (en) * 1994-11-15 1996-01-31 Bayer Ag Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
US6197791B1 (en) 1997-02-27 2001-03-06 American Cyanamid Company N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6720450B2 (en) 2001-12-13 2004-04-13 North Carolina State University Pesticidal activity of functionalized cyclopropanes
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
WO2005115384A2 (fr) * 2004-05-25 2005-12-08 Metabolex, Inc. Triazoles substitués bicyliques comme modulateurs de ppar et méthodes de préparation
CN1997633A (zh) * 2004-05-25 2007-07-11 麦它波莱克斯股份有限公司 作为ppar调节剂的取代的三唑及其制备方法
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
CA2702468A1 (fr) * 2007-10-12 2009-04-23 University Of Connecticut Applications therapeutiques d'inhibiteurs d'hydrolase d'amide d'acide gras
CN114075106B (zh) * 2020-08-12 2023-09-12 广东省稀有金属研究所 一种脂肪醇醚羧酸的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562330A (en) 1968-07-18 1971-02-09 Parke Davis & Co 2-phenoxy-4- and 5-phenyl-butyl and -pentyl-amines and salts
BE760034A (fr) * 1969-12-08 1971-06-08 Ici Ltd Production d'esters
FR2128277B2 (fr) * 1970-05-05 1979-06-22 Rorer Inc William H
DE3032669A1 (de) * 1979-09-07 1981-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
DE3662041D1 (en) 1989-03-16
NO871059L (no) 1987-03-13
EP0226636A1 (fr) 1987-07-01
EP0226636B1 (fr) 1989-02-08
GR861803B (en) 1986-11-10
NO871059D0 (no) 1987-03-13
JPS63500310A (ja) 1988-02-04
DK100487D0 (da) 1987-02-26
PT82987A (de) 1986-08-01
SU1708156A3 (ru) 1992-01-23
ATE40681T1 (de) 1989-02-15
KR870700599A (ko) 1987-12-30
AU6194286A (en) 1987-02-10
FI871143A7 (fi) 1987-03-16
PH25313A (en) 1991-04-30
FI871143A0 (fi) 1987-03-16
AU5988086A (en) 1987-01-22
NO166939B (no) 1991-06-10
DE3525284A1 (de) 1987-01-29
CA1316922C (fr) 1993-04-27
NZ216830A (en) 1990-11-27
PT82987B (pt) 1988-07-01
ZA865192B (en) 1987-03-25
DK100487A (da) 1987-02-26
WO1987000521A3 (fr) 1987-03-12
ES2001163A6 (es) 1988-05-01
AU595814B2 (en) 1990-04-12
NO166939C (no) 1991-09-18
WO1987000521A2 (fr) 1987-01-29
IL79379A0 (en) 1986-10-31
US4933367A (en) 1990-06-12

Similar Documents

Publication Publication Date Title
DD254193A5 (de) Verfahren zur herstellung von carbonsaeurederivaten
EP0612724B1 (fr) Benzène sulfonylurées et -thiourées substituées, procédé pour leur préparation et leur utilisation comme produits pharmaceutiques
DE19830430A1 (de) Schwefelsubstituierte Sulfonylamino-carbonsäure-N-arylamide, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE69105856T2 (de) Acetamidderivate.
EP0031954A2 (fr) Sulfonamides, procédé pour leur préparation et médicaments les contenant
DE2951135A1 (de) Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DE10024319A1 (de) Bisacylguanidine
EP0384279B1 (fr) Benzène sulfonamides et procédé pour leur préparation
DE3872620T2 (de) (arylsulphonyl)-nitromethane, verfahren zu deren herstellung und deren verwendung in pharmazeutischen zusammensetzungen.
CN1071743C (zh) 磺酰基或亚磺酰基苯甲酰基胍衍生物
DE3243158A1 (de) Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
EP0699660B1 (fr) Arylbenzoylguanidines
EP0279162B1 (fr) Dérivés d'acides carboniques, leur procédé de préparation et médicaments les contenant
EP1224166B1 (fr) Procede de fabrication de chlorhydrate de n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)-guanidine
EP0242767B1 (fr) N-dihydroindolyléthyl-sulfonamides
DE3210063A1 (de) Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
PT98530B (pt) Processo para a preparacao de derivados de anilina e de composicoes farmaceuti-cas que os contem
DE10129704A1 (de) Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks
EP1658266B1 (fr) Benzoylguanidines a substitution pentafluorosulfanylphenyle, leurs procedes de production, leur utilisation en tant que medicaments ou agents de diagnostic, ainsi que medicament les contenant
DE3134780A1 (de) "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"
DE3232959A1 (de) Substituierte benzolsulfonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0729954B1 (fr) Thiophénylurées et -thiourées, procédé pour leur préparation et leur utilisation comme médicament
DE69104304T2 (de) Amidobenzole.
AT266814B (de) Verfahren zur Herstellung von neuen Organosulffinyl- bzw. -sulfonylacylphenoxyalkansäuren und ihren Salzen
DD275454A5 (de) Verfahren zur herstellung von nitromethan

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee